Chairman, President & Chief Executive Officer
James Green is Chairman, President and Chief Executive Officer of Harvard Bioscience. He was named President and Chief Executive Officer in July 2019 and Chairman of the Board of Directors in June 2017. Green has been a member of the Company’s Board of Directors since April 2015. Green served as President and Chief Executive Officer of Analogic Corporation (NASDAQ: ALOG) from 2007 to 2016. While leading the public company through the great recession, Analogic’s core revenues grew over 50%, and gross margins, operating margins and earnings per share dramatically improved. Immediately prior to becoming President and Chief Executive Officer of Harvard Bioscience, Green served as President of Spacelabs Healthcare, where he led a successful global restructuring, rationalizing the company’s cost structure and product portfolio and quickly stabilized revenues while significantly improving operating margins. Earlier in his career, Green was Regional Vice President of a division of Quest Diagnostics Corporation, Sr. VP & General Manager of Koninklijke Philips Electronics NV Global Computed Tomography Business and held various leadership positions at St. Jude Medical Inc., Beckman Instruments, McDonnell Douglas Corporation and Northrop Advanced Systems. Green earned a bachelor’s degree in electrical engineering from the University of Missouri at Columbia and a master’s degree in computer engineering from the University of Southern California and is a graduate of the Stanford University Executive Program.
Chief Financial Officer
Michael Rossi was named Chief Financial Officer of Harvard Bioscience in July 2019. Immediately prior to joining the company, Rossi served as Chief Financial Officer of Laborie Medical Technologies. Prior to that role, he was Chief Financial Officer of Medical Specialties Distributors, a healthcare supply chain management solutions company, for over three years. Rossi brings significant experience with turnarounds and driving financial and operational improvements within complex middle market manufacturing and distribution businesses. He also has over fifteen years of public company accounting and reporting experience as well as experience managing debt and liquidity during both periods of growth and business downturns. Earlier in his career, Rossi held finance roles of increasing responsibility at various public companies, including Haemonetics Corporation, The Princeton Review, Inc., American Tower Corporation, Sonus Networks and Manufacturers’ Services Limited. He began his professional career as an accountant at PricewaterhouseCoopers. Rossi earned a Bachelor of Science in accounting from Babson College and a Masters of Business Administration from Babson College’s Olin School of Management.
Chief Operating Officer
Kenneth Olson has led global operations, supply chain and engineering since April 2020. Prior to that he served as Vice President and General Manager for Harvard Bioscience’s Pre-Clinical Business, recently acquired Data Sciences International (DSI). Prior to joining the company, Olson served as the Senior Vice President of Global Engineering and Operations at Spacelabs Healthcare. His previous roles include VP of R&D at ABT Molecular Imaging, where he created a biomarker generator that produced “on-demand” fluorine-18 and carbon-11 labeled compounds. He was the Vice President of R&D for Medtronic Physio-Control, where he oversaw the development of the LP15 Monitor/Defibrillator. Prior to Medtronic, Olson was the Chief Technical Officer for Cardiac Science, after a merger with Survivalink Corporation, where he served as the VP of R&D. Olson has over 40 issued patents in cardiology and resuscitation products. He has a Bachelor of Science in electrical engineering and a Master of Business Administration from the University of Minnesota.
Jacques Coumans Ph.D.
Chief Marketing Officer
Coumans was named Chief Marketing Officer of Harvard Bioscience in September 2020. Jacques has significant experience in bringing direction and focus into healthcare companies, from large/complex, to aspiring/mid-size and focused/private start-ups. He has over 35 years of experience of truly understanding the unmet needs of customers, defining a company’s product portfolio, formulating the right strategy, and creating the go-to-market story for the company. Prior to joining the company, he served as President of Hyperfine, a Connecticut start-up that developed and brought to market the world’s first portable MRI system. Before that, he was the Chief Marketing and Scientific Officer at Analogic and helped more than double revenues at Analogic’s Ultrasound business. He was General Manager at GE Healthcare for its Premium and interventional MRI business, and later he was Chief Marketing Officer for all of GE MRI. Earlier in his career he worked for Philips Healthcare, as research scientist in Germany, as MRI product manager in the Netherlands, as MR Key Account Manager for the top Universities in the USA, as CMO of Philips MR and as VP of Oncology in the Netherlands. Coumans earned a Master of Science in Applied Physics at Eindhoven University of Technology, and a Doctorate at the Carolina-Wilhelmina University in Braunschweig, Germany; he also was Adjunct Ass. Professor of Radiology at Emory University.
Vice President North America & APAC Sales, Cellular and Molecular Technologies
Don Stewart was named Vice President Sales, Americas and APAC, Cellular and Molecular Technologies in February 2020. Stewart focuses on CMT product sales to North American and Asia Pacific Academic Research Labs and brings more than 20 years of successful sales and business leadership experience to Harvard Bioscience. Most recently, prior to joining Harvard Bioscience, he served as Vice President Sales-Americas at Cole Parmer, a private equity portfolio company at GCTR and prior to that role held various business leadership positions within the research equipment and consumables space. At Cole Parmer, Stewart drove significant growth and profitability while expanding the commercial organization to meet customer needs. Stewart holds a BA in Management from Texas A&M University.
Vice President Global Sales, Preclinical Systems
Ryan Wallace was named Vice President Global Sales, Preclinical Systems in April 2020, where he leads our global direct sales concentrating on the leading Clinical Research Organizations (CROs), pharmaceutical companies and certain strategic accounts. Wallace joined the company in January 2020, bringing extensive leadership and strategic selling experience and large account management of healthcare Integrated Delivery Networks, including over a decade of consecutive year-over-year double digit growth. Immediately prior to joining Harvard Bioscience, Wallace was a sales leader and top performer with Spacelabs Healthcare where he amassed a wealth of experience in healthcare capital equipment and service sales. Wallace has a BBA from Texas Lutheran University in Marketing and Management.